The Medical Research Council Impact Acceleration Account (MRC IAA) awarded the University of Kent £457,000 to flexibly support a wide range of translational research projects. This award aims to accelerate the transition from early discovery research towards patient benefit.
MRC IAA Objectives
Deliver a fast, flexible see-funding strategy for researchers
Promote innovative forms of interaction and knowledge exchange between key translational stakeholders including industry, clinical and third sector organisations
Provide training and mentoring to generate new translational research
Develop new interdisciplinary consortia in areas of research strength at the University of Kent.
If you are a member of Kent staff, you can find out more about our IAA strategy, upcoming funding rounds and eligibility criteria on our intranet.
Our aim is to build on the University of Kent's strong foundation in Biomedical and clinical research, and enable a step change in the activity, impact, and ultimate success of our translational research pipeline.
Current opportunities
Rapid Response Fund (RRF) - Open call
To initiate or strengthen engagement with other stakeholders, for consortia building activities or training purposes.
Management of percutaneous endoscopic gastrostomy (PEG)
tubes in the community.
Dr Darren Griffin
School of Biosciences
Novel imaging and artificial intelligence (AI)
strategies to improve assisted reproduction outcomes.
Professor Neil Kad
School of Biosciences
De-risking the development of novel adjuvant
antimicrobial drugs.
Professor Dan Mulvihill
School of Biosciences
Low-cost high yield antibodies for diagnostics.
Lead
School
Project
Dr
Marina Escurra
School
of Biosciences
Ageing
stronger is ageing better: development of new biomarkers and interventions to
prevent sarcopenia and promote healthy ageing.
Dr
Perry Hailey
School
of Biosciences
Accelerating
the development of supramolecular self-associated amphiphile-based drug
molecules for the treatment of bladder cancer from laboratory to the clinic.
Dr
David Kelly
School
of Psychology
Using
eye-tracking to explore links between perinatal mental illness and autism in
the first two years of life.
* Funding round harmonised with Biotechnology and Biological Sciences Research Council IAA.
Lead
School
Project
Dr
Helen Cockerton*
School
of Biosciences
Anti-cancer
hops.
Dr
Marta Farre Belmonte*
School
of Biosciences
Detecting
structural and sequence level genetic variation in a single diagnostic assay.
Dr
Sanaul Hoque
School
of Engineering
Smart
assistive mobility for remote clinical monitoring and diagnosis.
Prof:
Robert Horne
School
of Engineering
Development
of a printed patient centric device for measurement of wound healing and
nutritional status.
Dr
Michael Hughes
School
of Physics and Astronomy
The OCT
Pen: Clinical feasibility and network building.
Dr
Mohinder Pal*
School
of Biosciences
RUVBL1
and RUVBL2 as therapeutic targets for non-small cell lung cancer.
Dr
Palaniappan Ramaswamy
School
of Computer Science
Vagus
Nerve Stimulation for motion sickness treatment.
